EUVIMEDEUVIMED entdecken
Crossref

Blockade of Interferon‐Induced Protein 35 Alleviates Cisplatin‐Induced Ferroptosis in Acute Kidney Injury Through Activation of the NRF2

Juan Zhou, Ye Liu, Fang Sun iD

Journal of Biochemical and Molecular Toxicology · 2025

DOI: 10.1002/jbt.70383 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Juan Zhou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Yantaishan Hospital, Yantai, Shandong, China. Hauptthemen laut MEDLINE: Cisplatin, Ferroptosis, Acute Kidney Injury, NF-E2-Related Factor 2. Die Arbeit nennt 55 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferroptosis is a non‐regulatory cell death closely related to the process of cisplatin‐induced acute kidney injury (AKI). We sought to explore the ability of inhibited Interferon‐induced protein 35 (IFI35) to alleviate cisplatin‐induced AKI by modulating ferroptosis. Expression of IFI35 was investigated in the cisplatin‐induced AKI mouse model and cisplatin‐induced HK2 cells. The potential molecular mechanisms were examined in cells by detecting ferroptosis‐related indicators following the addition of ferroptosis inducer (Erastin) and the antioxidant transcription factor NRF2 pathway inhibitor (ML385), respectively. Higher levels of IFI35 were observed in AKI mouse model and HK2 cells. IFI35 deficiency enhanced cell viability and antioxidant capacity, reducing ferroptosis‐related parameters like Fe 2+ accumulation and ROS production while upregulating GPX4 and FSP1 protein levels. In mice, IFI35 blockade attenuated cisplatin‐induced renal injury, as evidenced by decreased serum urea nitrogen and creatinine levels, and improved histopathological changes. Mechanistically, IFI35 inhibition reduced peroxide production, reversed iron‐dependent mitochondrial damage, and inhibited ferroptosis via upregulating NRF2 activity. Our study suggested that IFI35 inhibition inhibits ferroptosis in AKI by upregulating NRF2 expression, targeting IFI35 may offer a promising therapeutic option for AKI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinFerroptosisAcute Kidney InjuryNF-E2-Related Factor 2Mitochondrial ProteinsAnimalsMiceMaleHumansCell LineMice, Inbred C57BL

Stichwörter der Autor:innen

acute kidney injuryferroptosisinterferon‐induced protein 35nuclear factor E2‐related factor 2renal tubular epithelial cells

Substanzen

CisplatinNF-E2-Related Factor 2Nfe2l2 protein, mouseMitochondrial Proteins

Autor:innen und Institutionen

  • Department of Nephrology, Yantaishan Hospital, Yantai, Shandong, China.
  • Department of Nephrology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong, China.

ORCID-Profile: Fang Sun

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Zhou, J., Liu, Y., & Sun, F. (2025). Blockade of Interferon‐Induced Protein 35 Alleviates Cisplatin‐Induced Ferroptosis in Acute Kidney Injury Through Activation of the NRF2. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70383

Vancouver

Zhou J, Liu Y, Sun F. Blockade of Interferon‐Induced Protein 35 Alleviates Cisplatin‐Induced Ferroptosis in Acute Kidney Injury Through Activation of the NRF2. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70383

BibTeX
@article{Zhou2025,
  author = {Zhou, Juan and Liu, Ye and Sun, Fang},
  title = {Blockade of Interferon‐Induced Protein 35 Alleviates Cisplatin‐Induced Ferroptosis in Acute Kidney Injury Through Activation of the NRF2},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2025},
  doi = {10.1002/jbt.70383}
}
Kostenlos starten →